Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiko Yamamoto is active.

Publication


Featured researches published by Yoshihiko Yamamoto.


European Journal of Applied Physiology | 1993

Changes in cardiac rhythm in man during underwater submersion and swimming studied by ECG telemetry.

Hisao Yamaguchi; Hiroyuki Tanaka; Shigeru Obara; Shingo Tanabe; Noboru Utsuyama; Akira Takahashi; Jun Nakahira; Yoshihiko Yamamoto; Zhen-Lin Jiang; Jufang He; Eizo Bando; Hiroshi Miyamoto

SummaryA previously reported method for electrocardiographic (ECG) telemetry in water using frequency-modulated current was improved to obtain more stable ECGs. The ECGs of seven healthy men were monitored using the improved method during and after whole-body submersion or underwater swimming. Bradycardia and arrhythmias were observed during the submersion, and transient tachycardia was detected after the start of underwater swimming, followed by bradycardia with arrhythmias. Three different types of arrhythmias were observed: sinus arrhythmia (SA), supraventricular extra-systole (SE) and ventricular extrasystole (VE). SA and SE tended to develop during the latter half of the period of submersion or underwater swimming, and especially after the restart of breathing. VEs were detected in only one subject during submersion, whereas they occurred in most subjects during and after underwater swimming. Individual variations were found in development of arrhythmias, one subject showing no arrhythmia. Bradycardia, SA and SE could depend on vagal suppression in underwater conditions, and VE may be related to the effect of muscular movement on cardiac function in addition to vagal inhibiton.


Virus Genes | 1997

Functional Analysis of vif Genes Derived from Various Primate Immunodeficiency Viruses

Saburo Sone; Yoshihiko Yamamoto; Akio Adachi; Jin Asano; Shinya Iida; Yasuyoshi Saito

Replication property in cells of human and simian immunodeficiency viruses (HIVs and SIVs) lacking intact vif gene was evaluated. Of 10 vif mutants constructed in vitro of the major four HIV/SIV groups, only those derived from HIV-1 and HIV-2/SIVmac displayed replication defect. The cell lines non-permissive for the vif mutants of HIV-1 and SIVmac were found to be different. To determine whether Vif is exchangeable between HIV-1 and SIVmac, chimeric virus clones with respect to the vif gene were constructed and virus replication in the cells non-permissive for the vif mutant viruses was monitored. Productive infection in these cells of chimeric viruses clearly indicated that Vif is functionally exchangeable, and that Vifs of different virus origin act through a similar mechanism.


Journal of Cancer Research and Clinical Oncology | 1996

Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells

Eiji Shimizu; Yasutake Takahashi; Akinori Shinohara; Yoshihiko Yamamoto; Seiji Yoshida; Akiyoshi Yamamoto; Saburo Sone; Yoichi Takaue; Takeshi Ogura

The biological effects of c-kit ligand (stem-cell factor: SCF) on an immortalized human megakaryocytic cell line (CMK) was evaluated using methods including the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, surface marker analysis, DNA cell-cycle analysis and immunoblotting. SCF stimulated the growth of CMK cells. Incubation with SCF resulted in increased expression of IIb/IIIa platelet-related glycoprotein (gpIIb/IIIa), indicating enhanced differentiation of CMK cells. Treatment of CMK cells with SCF resulted in a decrease in the subpopulation in the G1 phase, with a reciprocal increase in those in the S phase and the G2+M phase. Moreover, SCF significantly increased cellular expression of cyclin A, a regulatory subunit of cyclin-dependent protein kinase (CDK), and the ratio of phosphorylated/dephosphorylated retinoblastoma gene product (RB protein). These results suggest that SCF stimulates the growth and differentiation of megakaryocytic cells possibly through mechanisms related to the activation of cell-cycle-dependent serine/threonine kinase and inactivation of the nuclear tumor-suppressor gene product.


Journal of AIDS and Clinical Research | 2010

Estimating CD4+ cell counts of an individual using population historical data.

Toshio Makie; Noriko Ishida; Todd Saunders; Yoshihiko Yamamoto; Tsuyoshi Nakamura

+ cell count; Total lymphocyte count; Sample-based prediction method; Individual-based prediction method; Sensitivity; Predictive-positive rate Abstract Background and objective: WHO guidelines in 2010 no longer recommend the total lymphocyte count (TLC), instead of the CD4 + cell (CD4) count, in deciding on the initiation of anti-retroviral treatment. This is very problematic because of the cost and resources involved in getting CD4 counts. To solve this problem, we developed an efficient and reliable method for predicting CD4 counts based on a previous CD4 count. Subjects and methods: To surmount the degrading of the precision due to the individual variability in CD4 counts, we developed an individual-based prediction method. Results: The sensitivity and the predictive-positive rate of CD4 counts below 350 cells/mm 3 were 89% and 88%, respectively, at a one-month interval and 76% and 84%, respectively, at a six-month interval. Conclusion: The individual-based prediction method of the CD4 count will be useful and critical in resource-poor regions where CD4 counts are not repeatedly available.


The Journal of Medical Investigation | 2007

Convalescence of atypical reversible posterior leukoencephalopathy syndrome in human immunodeficiency virus infection

Rie Tanioka; Yoshihiko Yamamoto; Mio Sakai; Toshio Makie; Masahiko Mori; Tomoko Uehira; Takuma Shirasaka


Biochemical and Biophysical Research Communications | 1998

Inhibition of HIV Replication by Capsid Mutant C6b

Reika Shimano; Shinya Iida; Tomoharu Fukumori; Yoshihiko Yamamoto; Meiko Kawamura; Rika A. Furuta; Akio Adachi


International Journal of Cancer | 1996

Establishment and characterization of two cultured cell lines derived from malignant rhabdoid tumors of the kidney

Masao Hirose; Tadashi Yamada; Tatsuo Abe; Takanori Hirose; Eiji Shimizu; Yoshihiko Yamamoto; Shoji Kagami; Shoichi Takano; Toshikazu Yamaguchi; Yasuhiro Kuroda


The Journal of Medical Investigation | 2007

Generation and characterization of APOBEC3G-positive 293T cells for HIV-1 Vif study

Ahmad Piroozmand; Yoshihiko Yamamoto; Boonruang Khamsri; Mikako Fujita; Tsuneo Uchiyama; Akio Adachi


Oncology Reports | 1998

RB protein status and chemosensitivity in non-small cell lung cancers.

Yoshihiko Yamamoto; Eiji Shimizu; N Masuda; M Takada; Saburo Sone


The Journal of Medical Investigation | 2008

Problems in three Japanese drug users with Human Immunodeficiency Virus infection

Takeshi Kuwahara; Takahiro Nakakura; Sachiko Oda; Masahiko Mori; Tomoko Uehira; Gaku Okamoto; Munehiro Yoshino; Atsushi Sasakawa; Keishiro Yajima; Aiko Umemoto; Kiyonori Takada; Toshio Makie; Yoshihiko Yamamoto

Collaboration


Dive into the Yoshihiko Yamamoto's collaboration.

Top Co-Authors

Avatar

Akio Adachi

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Saburo Sone

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Eiji Shimizu

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Tomoko Uehira

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shinya Iida

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Takuma Shirasaka

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge